دورية أكاديمية
Clozapine-associated neutropenia following augmentation with sodium valproate
| العنوان: | Clozapine-associated neutropenia following augmentation with sodium valproate |
|---|---|
| المؤلفون: | Michelle Iris Jakobsen, H Grønborg, H V Hansen, A Fink-Jensen |
| المصدر: | SAGE Open Medical Case Reports, Vol 9 (2021) |
| بيانات النشر: | SAGE Publishing, 2021. |
| سنة النشر: | 2021 |
| المجموعة: | LCC:Medicine (General) |
| مصطلحات موضوعية: | Medicine (General), R5-920 |
| الوصف: | Clozapine is gold standard for the management of treatment-resistant schizophrenia. It can offer life-changing symptom reduction where other antipsychotics have failed, and for these patients, treatment with clozapine should be maintained, if in any possible way. However, treatment with clozapine comes with a risk of developing potentially fatal adverse reactions, for example, severe neutropenia or agranulocytosis, in which case, treatment must be discontinued. Here, we present a case of clozapine-related neutropenia that commenced after the addition of sodium valproate. A subsequent re-challenge to clozapine resulted in severe neutropenia and led to the permanent cessation of clozapine treatment. The patient had been tolerating clozapine for more than a year before the addition of sodium valproate. The awareness of an interaction between clozapine and sodium valproate could help reduce the risk of clozapine-induced neutropenia and subsequent clozapine discontinuation. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2050-313X 2050313X |
| Relation: | https://doaj.org/toc/2050-313X |
| DOI: | 10.1177/2050313X211019791 |
| URL الوصول: | https://doaj.org/article/5576afc4b5e34be28c266772670d19d6 |
| رقم الأكسشن: | edsdoj.5576afc4b5e34be28c266772670d19d6 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 2050313X |
|---|---|
| DOI: | 10.1177/2050313X211019791 |